Search clinical trials for: DMARDs: Disease-modifying antirheumatic drugs

Total 255701 results

University Hospital Bispebjerg and Frederiksberg

Active, not recruiting

Assessing Pain by the painDETECT Questionnaire (PDQ)

Rheumatoid Arthritis | Spondylarthropathies | Inflammatory Arthritis | Psoriatic Arthritis
Hoffmann-La Roche

Completed

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

Juvenile Idiopathic Arthritis
Mycenax Biotech Inc.

Unknown

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

Combination With DMARDs

Taiwan
Pfizer

Completed

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

Rheumatoid Arthritis

Hungary, Qatar, Romania, Ukraine, China, Czech Republic, Malaysia, Thailand, Lebanon, South Africa, Philippines, Brazil, Colombia, Egypt, Jordan, Mexico, Russian Federation, Taiwan, United Arab Emirates
University of Cagliari
University of Turin, Italy; University Hospital, Udine, Italy; Azienda Sanitaria... and other collaborators

Unknown

Ultrasound in Psoriatic Arthritis Treatment (UPSTREAM)

Arthritis, Psoriatic | Ultrasonography | Minimal Disease, Residual

Italy
Hoffmann-La Roche

Completed

A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 (RITACT)

Arthritis, Rheumatoid

Brazil
DNAlytics
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Unknown

Predictive Analytics for Theranosis in RA (PAnTheRA)

Rheumatoid Arthritis

Belgium, Spain
Alliancells Bioscience Corporation Limited

Unknown

Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

China
University Hospital, Montpellier

Completed

Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients (ProCOVRA)

Covid19 | Rheumatoid Arthritis

France
Fundación Santa Fe de Bogota

Unknown

Predictive Factors for COVID-19 in Rheumatology

Covid19 | Rheumatic Diseases
Liga Panamericana de Asociaciones de Reumatologia...

Recruiting

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (PREJAK)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis

Argentina
Pfizer

Completed

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

Rheumatoid Arthritis

Denmark
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Rheumatoid Arthritis

Italy
Scios, Inc.

Completed

SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

Arthritis, Rheumatoid
Diakonhjemmet Hospital
Oslo University Hospital; University Hospital of North Norway; Helse Nord-Trøndelag... and other collaborators

Recruiting

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors (RIMRA)

Immune-related Adverse Event

Norway
Kasr El Aini Hospital

Active, not recruiting

Biologic Therapy in Pediatric JIA Uveitis

Juvenile Idiopathic Arthritis Associated Uveitis

Egypt
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
National Taiwan University Hospital

Unknown

Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Taiwan
GlaxoSmithKline
Iqvia Pty Ltd

Terminated

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) (contRAst 2)

Arthritis, Rheumatoid

United States, Australia, Germany, Japan, Korea, Republic of, Poland, Bulgaria, Estonia, Hungary, Mexico, Russian Federation, Spain, Thailand, Colombia, China, Argentina, United Kingdom, France
National Institute of Medical Sciences and Nutrition...

Recruiting

INCMNSZ - Rheumatoid Arthritis Cohort (IRAC)

Rheumatoid Arthritis | Early Rheumatoid Arthritis

Mexico
Hoffmann-La Roche

Completed

A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Rheumatoid Arthritis

United States
University of Leeds

Completed

Very Early Versus Delayed Etanercept in Patients With RA (VEDERA)

Rheumatoid Arthritis

United Kingdom
Assiut University

Unknown

Adherence Rate to DMARDS in Egyptian Patients With RA

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

Rheumatoid Arthritis

Portugal
Biocad

Completed

Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis (BIORA)

Rheumatoid Arthritis

India, Russian Federation, Belarus, Ukraine
Assistance Publique - Hôpitaux de Paris
French Society of Rheumatology

Completed

Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study (STRASS)

Rheumatoid Arthritis

France
Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants

Rheumatoid Arthritis

Italy
Amgen

Completed

A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis
Umm Al-Qura University

Recruiting

"Comparative Effect of Different Drugs Used to Tr€at Patients in Rheumatoid Arthritis Saudi Database (RASD)"

Rheumatoid Arthritis RA
Hoffmann-La Roche

Completed

A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

Italy
Zhang, Xiao, M.D.
Xijing Hospital; Tianjin Medical University General Hospital; Central South University

Unknown

Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients (INNOVATION)

Rheumatoid Arthritis（RA）

China
Hoffmann-La Roche

Completed

A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Rheumatoid Arthritis

Russian Federation
Nanfang Hospital of Southern Medical University
Southern Medical University, China

Unknown

Long-term Prognosis and Quality of Life in Early Rheumatoid Arthritis Patients Treated by 2015 ACR Guideline (LELAND) (LELAND)

Rheumatoid Arthritis
University of Nebraska

Recruiting

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Rheumatoid Arthritis

United States
Medical University of Graz

Terminated

Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis (RA-BioStop)

Rheumatoid Arthritis

Austria
Sanjay Gandhi Postgraduate Institute of Medical...

Completed

Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain

Seronegative Spondyloarthropathies

India
Chengdu PLA General Hospital

Unknown

Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases

Chronic Rheumatic Diseases

China
Tuen Mun Hospital

Not yet recruiting

Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT

Herpes Zoster

China
Asan Medical Center

Unknown

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Cancer | Lung Cancer Metastatic | Immunotherapy

Korea, Republic of
JW Pharmaceutical

Completed

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

South Africa
Janssen Research & Development, LLC

Terminated

An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement (RECOVERY)

Spondylitis, Ankylosing

China
Nanfang Hospital of Southern Medical University

Completed

Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS

Ankylosing Spondylitis

China
National and Kapodistrian University of Athens

Recruiting

Cortisol Circadian Rhythm in Patients With RA (CortRyRA)

Rheumatoid Arthritis

Greece
Amgen

Completed

Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) (APPRAISE)

Arthritis, Psoriatic

Canada
Hoffmann-La Roche

Completed

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

France, Germany, Italy, Spain, United Kingdom, Hong Kong, United States, Colombia, Brazil, Canada, New Zealand, South Africa, Philippines, Russian Federation, Thailand, Singapore, Bulgaria, Mexico, Australia, Lithuania, Poland, Ar... and more
Bristol-Myers Squibb

Recruiting

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Psoriatic Arthritis

Italy, United States, Australia, Argentina, Brazil, Czechia, France, Hungary, Mexico, Russian Federation, China, Poland, Finland, Colombia, United Kingdom, Bulgaria, Taiwan, Chile, Romania, Spain, Ireland
Shenzhen Hornetcorn Bio-technology Company, LTD
Futian People's Hospital

Unknown

Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis

Rheumatoid Arthritis

China
Fundación Eduardo Anitua

Not yet recruiting

Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva (PRGF)

Lichen Sclerosus of Vulva
Qilu Hospital of Shandong University

Active, not recruiting

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Connective Tissue Diseases | Interstitial Lung Disease | Pirfenidone

China

3

Subscribe